Sunday, July 21, 2024

SEQSTER partners with Antidote Technologies for clinical trial enrollment

Must Read

Antidote Technologiesa digital patient engagement company, announced it will partner with SEQSTER, a multidimensional healthcare data platform, to identify patients for clinical trials and improve trial timelines.

Antidote offers a clinical trial patient recruitment platform that includes patient screening and support services.

The company will leverage SEQSTER’s operating system to better match patients to clinical trials based on their genomic data, lifestyle factors and medical history.

“Partnering with SEQSTER allows us to enhance our precision recruitment process with unparalleled data integration capabilities, ensuring we can more effectively identify the right participants and reduce the time it takes to bring new treatments to market,” Samantha Veeck, co-CEO of Antidote, said in a statement.

THE BIGGEST TREND

In December, San Diego-based SEQSTER partnered with a Palo Alto-based real-world data platform. Atropos Health will improve diversity and inclusion in clinical trials by creating turnkey patient registries to accelerate evidence generation.

In March, SEQSTER partnered with the Multiple Sclerosis Association of America to use data to bring together people living with MS, researchers, and care centers across the country.

Three months later, a decentralized clinical trials company Thread and SEQSTER partner to access real-world data for life sciences companies, researchers, and patients.

Another company focused on improving the clinical trial experience is oncology-focused digital health company. Flatiron Health, which Roche acquired in 2018.

In May, iron announced a strategic collaboration with the Association of Cancer Care Centers to promote access to clinical trials in the community setting, improve the efficiency of clinical trials, and enhance the collection of study-related data.

Start of clinical trial Inato, the Digital Medicine Society (DiMe), clinical trial technology company Science 37, and clinical trial platform powered by Paradigm are also participating in this space.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest News

Insider names 8 potential trade targets for the Lakers

The Los Angeles Lakers once again entered the offseason with high hopes and expectations. There was a lot of...

More Articles Like This